-
Front line treatment of elderly multiple myeloma in the era of novel agents.
Venon MD, Roccaro AM, Gay J, Moreau AS, Dulery R, Facon T, Ghobrial IM, Leleu X.
Biologics. 2009; 3:99-109. Epub 2009 Jul 13.
[Biologics. 2009]
-
Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.
Borgioli A, Viviani C, Duvina M, Brancato L, Spinelli G, Brandi ML, Tonelli P.
Ther Clin Risk Manag. 2009 Feb; 5(1):217-27. Epub 2009 Mar 26.
[Ther Clin Risk Manag. 2009]
-
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Aragon-Ching JB, Ning YM, Chen CC, Latham L, Guadagnini JP, Gulley JL, Arlen PM, Wright JJ, Parnes H, Figg WD, et al.
Cancer Invest. 2009 Feb; 27(2):221-6.
[Cancer Invest. 2009]
- » See all...